J&J set to acquire Aragon in $1 billion deal

Johnson & Johnson is set to bolster its position within the field of prostate cancer through the acquisition of Aragon Pharmaceuticals in a deal that could be worth up to $1 billion.

Read more ...

European companies at risk of losing three quarters of their talent in the next 12 months

European pharma, biotech and medical devices companies are at risk of losing three quarters of their best people in the next 12 months according to a new report published by Real.

Read more ...

Obamacare taxes pose significant risk to US medical devices industry

Barack Obama’s medical device tax is not just unfair but is killing jobs, limiting potential treatments and has the potential to cost lives according to USA Today.

Read more ...

2013 Singapore DIA conference

Raffles City Convention Centre | 252 North Bridge Road Singapore | 179103 Singapore | 28th - 30th January

Attracting more than 300 professionals this year’s DIA Meeting promises to be the best yet.

Read more ...